Lpl Financial LLC United Therapeutics Corp Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Lpl Financial LLC holds 6,392 shares of UTHR stock, worth $2.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,392

Previous 6,172 3.56%

Holding current value

$2.41 Million

Previous $1.97 Million 16.48%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$311.04 - $363.55 $68,428 - $79,981	220 Added 3.56%	6,392 $2.29 Million
Q2 2024 Aug 07, 2024	BUY	$228.26 - $319.04 $20,543 - $28,713	90 Added 1.48%	6,172 $1.97 Million
Q1 2024 May 10, 2024	BUY	$210.76 - $249.51 $114,442 - $135,483	543 Added 9.8%	6,082 $1.4 Million
Q4 2023 Feb 14, 2024	SELL	$214.88 - $256.94 $36,744 - $43,936	-171 Reduced 2.99%	5,539 $1.22 Million
Q3 2023 Nov 13, 2023	BUY	$211.82 - $248.24 $38,974 - $45,676	184 Added 3.33%	5,710 $1.29 Million
Q2 2023 Jul 31, 2023	SELL	$205.19 - $232.99 $71,816 - $81,546	-350 Reduced 5.96%	5,526 $1.22 Million
Q1 2023 May 10, 2023	BUY	$212.99 - $276.17 $126,729 - $164,321	595 Added 11.27%	5,876 $1.32 Million
Q4 2022 Feb 07, 2023	SELL	$205.95 - $280.43 $101,739 - $138,532	-494 Reduced 8.55%	5,281 $1.47 Million
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $28,868 - $34,672	-142 Reduced 2.4%	5,775 $1.21 Million
Q2 2022 Aug 12, 2022	BUY	$174.81 - $241.14 $544,358 - $750,909	3,114 Added 111.1%	5,917 $1.39 Million
Q1 2022 May 16, 2022	BUY	$166.16 - $213.96 $76,932 - $99,063	463 Added 19.79%	2,803 $503,000
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $8,110 - $9,507	-44 Reduced 1.85%	2,340 $506,000
Q3 2021 Nov 15, 2021	SELL	$179.86 - $214.88 $3,956 - $4,727	-22 Reduced 0.91%	2,384 $440,000
Q2 2021 Aug 13, 2021	BUY	$170.47 - $211.93 $18,410 - $22,888	108 Added 4.7%	2,406 $432,000
Q1 2021 May 14, 2021	SELL	$153.94 - $174.85 $138,238 - $157,015	-898 Reduced 28.1%	2,298 $384,000
Q4 2020 Feb 12, 2021	BUY	$101.87 - $151.79 $80,579 - $120,065	791 Added 32.89%	3,196 $485,000
Q3 2020 Nov 09, 2020	BUY	$99.9 - $121.13 $22,377 - $27,133	224 Added 10.27%	2,405 $243,000
Q2 2020 Aug 13, 2020	SELL	$92.74 - $125.82 $28,563 - $38,752	-308 Reduced 12.37%	2,181 $264,000
Q1 2020 May 14, 2020	BUY	$79.39 - $115.35 $5,319 - $7,728	67 Added 2.77%	2,489 $236,000
Q4 2019 Feb 14, 2020	BUY	$78.31 - $95.34 $189,666 - $230,913	2,422 New	2,422 $213,000
Q4 2018 Feb 07, 2019	SELL	$101.4 - $128.73 $192,964 - $244,973	-1,903 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$113.81 - $129.46 $10,811 - $12,298	-95 Reduced 4.75%	1,903 $243,000
Q2 2018 Aug 14, 2018	BUY	$101.14 - $118.31 $202,077 - $236,383	1,998 New	1,998 $226,000

Others Institutions Holding UTHR

# of Institutions

671

Shares Held

42.4M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC United Therapeutics Corp Transaction History